Rennova Health Stock Forecast, Price & News

Wall Street analysts have given Rennova Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Rennova Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Rennova Health saw a increase in short interest in July. As of July 15th, there was short interest totaling 289,100 shares, an increase of 83.1% from the June 30th total of 157,900 shares. Based on an average daily trading volume, of 665,145,400 shares, the days-to-cover ratio is currently 0.0 days.
View Rennova Health's Short Interest.

Rennova Health is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for Rennova Health.

Rennova Health, Inc. (OTCMKTS:RNVA) released its quarterly earnings data on Tuesday, August, 14th. The company reported $250,000.00 earnings per share (EPS) for the quarter. The business earned $3.29 million during the quarter.
View Rennova Health's earnings history.

Rennova Health's stock was trading at $0.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RNVA stock has decreased by 47.0% and is now trading at $0.0530.
View which stocks have been most impacted by COVID-19.

Shares of Rennova Health reverse split on the morning of Monday, July 19th 2021. The 1-1000 reverse split was announced on Monday, July 19th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 19th 2021. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.

Some companies that are related to Rennova Health include Community Health Systems (CYH), SunLink Health Systems (SSY), First Physicians Capital Group (FPCG), Ethema Health (GRST) and Nobilis Health (HLTH).
View all of RNVA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), CytRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP), Protalix BioTherapeutics (PLX) and 22nd Century Group (XXII).

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RNVA stock can currently be purchased for approximately $0.05.

Rennova Health has a market capitalization of $530 million and generates $7.20 million in revenue each year.

Rennova Health employs 63 workers across the globe.

The official website for Rennova Health is www.rennovahealth.com.

Rennova Health is headquartered at 931 Village Boulevard Suite 905, West Palm Beach FL, 33409.

Rennova Health's mailing address is 931 Village Boulevard Suite 905, West Palm Beach FL, 33409. The company can be reached via phone at 561-855-1626 or via email at [email protected]